...
机译:Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic
Univ Basque Country UPV EHU, Donostia Univ Hosp, Biodonostia Hlth Res Inst, CIBERehd,Ikerbasque;
Univ Padua, Dept Mol Med DMM, Padua, Italy;
Padua Univ Hosp, Div Gen Med, Padua, ItalyChristie NHS Fdn, Dept Med Oncol, Manchester, Lancs, EnglandSorbonne Univ, INSERM, Ctr Rech St Antoine CRSA, Paris, FranceAzienda ULSS2 Marca Trevigiana, Dept Pathol, Treviso, ItalyPadua Univ Hosp, Hepatobiliary Surg & Liver Transplantat, Padua, ItalyUniv Milano Bicocca, Int Ctr Digest Hlth ICDH, Milan, ItalyUniv Salamanca, IBSAL, CIBERehd, Expt Hepatol & Drug Targeting HEVEPHARM, Salamanca, Spain;
Cholangiocyte; cholangiocarcinoma; extrahepatic cholangiocarcinoma; epithelial-to-mesenchymal transition; immunotherapy; molecularly targeted therapies; oncogenic drivers; tumor microenvironment;